Resverlogix Corp. announced a partnership to support planned commercialization of apabetalone in the United States, Canada (where authorization has been granted to conduct clinical studies of apabetalone for COVID-19) and/or potentially expanding to additional global markets, as Emergency Use Authorization and/or a New Drug Application or equivalent is issued or approved. In preparation for launch, Resverlogix will utilize EVERSANA’s fully integrated commercialization services that include market access, agency services, clinical and commercial field teams, medical science liaisons, channel management, patient services, health economics and outcomes research, and compliance, with each service optimized by data and predictive analytics.
EVERSANA, a pioneer of next generation commercial services to the global life sciences industry, on May 6 announced key appointments across Europe to further strengthen the company’s worldwide market access and pricing solutions leadership position.
Leading life science commercialization partner Fishawack Health acquired PRMA Consulting, a premier global market access and health economics outcomes research (HEOR) consultancy with offices across Europe, Asia, and the United States.
FCB Health Network president & CEO Dana Maiman announced Jill Lesiak joined Mosaic Group – the Network’s full-service payer and market access healthcare agency – as executive creative director.
Huntsworth, an international healthcare and communications group, announced an agreement to acquire Nucleus Global, one of the world’s largest medical specialist communications groups.
EVERSANA™ expands pharmaceutical training and digital engagement capabilities with acquisition of Alkemy Partners CHICAGO, Sept. 9, 2020 /PRNewswire/ — EVERSANA™, the leading provider of commercial services to the life science industry, today announced the acquisition of Alkemy Partners, a full-service field learning and development company committed to solving market access, sales and clinical engagement through training, […]
EVERSAN and Havas Health & You announced an exclusive strategic partnership agreement, inclusive of data, analytics and predictive platforms, combined with commercialization services, to offer to health and wellness clients worldwide.
Global healthcare communications agency Fishawack Health acquired Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the United States.
EVERSANA launched full-solution healthcare marketing agency EVERSANA ENGAGE, which is uniquely designed to help pharma and biotech companies cohesively reach patients, payers and providers to enhance the patient experience and improve outcomes.
As part of Fingerpaint’s continued commitment to bring forward the best opportunities to their clients, the full-service health and wellness marketing agency acquired 1798, a market access and commercialization firm located in La Jolla, Calif.